Beyond NPS: Unlocking Customer Advocacy
The world of women’s healthcare is primed for disruption, at least if you’re talking to the women who comprise the market of this $10B*+ industry – and we are.
In this report, we reimagine women’s healthcare with everyday women leading the charge. This does not mean that the industry surrenders its expertise, infrastructure or creative vision; it simply shifts the direction of influence so that the industry mirrors the innovation formula of other breakthrough brands of the 21st century. One where patients illuminate challenges, and professionals pioneer solutions.
Download below to explore the fundamental problems that women’s healthcare needs to address, and the roadmap to success.
*“Women’s Health Care Market by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause) – Global forecast to 2024.” Markets and Markets, https://www.marketsandmarkets.com/Market-Reports/womens-health-care-market-136585329.html. Accessed 8 July 2021.